Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-21 Purchase | 2024-10-23 7:53 pm | Inhibikase Therapeutics Inc. | IKT | Bellini Roberto Director | 1,460,000 | $1.37 | $2,000,200 | 1,520,000 (Indirect Direct) | View |
| 2024-10-21 Purchase | 2024-10-23 7:49 pm | Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director | 145,000 | $1.37 | $198,650 | 205,000 (Direct) | View |
| 2024-10-21 Purchase | 2024-10-23 7:43 pm | Inhibikase Therapeutics Inc. | IKT | Munshi Amit Director | 365,000 | $1.37 | $500,050 | 425,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-14 Option Award | 2025-04-16 4:06 pm | N/A 2035-04-14 | Inhibikase Therapeutics Inc. | IKT | McIntyre David Chief Financial Officer | 1,775,539 | $0 | 1,775,539 (Direct) | View |
Ownership | 2025-04-16 4:05 pm | N/A N/A | Inhibikase Therapeutics Inc. | IKT | McIntyre David Chief Financial Officer | 0 | $0 | 10,285 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 4:10 pm | N/A 2035-02-21 | Inhibikase Therapeutics Inc. | IKT | Cabell Christopher President & Head of R&D | 1,100,705 | $0 | 1,100,705 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 4:10 pm | N/A 2035-02-21 | Inhibikase Therapeutics Inc. | IKT | Aurentz Vincent Director | 134,427 | $0 | 134,427 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 4:05 pm | N/A 2035-02-14 | Inhibikase Therapeutics Inc. | IKT | Iwicki Mark T Chief Executive Officer | 602,346 | $0 | 602,346 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:26 pm | N/A 2035-02-14 | Inhibikase Therapeutics Inc. | IKT | Iwicki Mark T Chief Executive Officer | 6,168,148 | $0 | 6,168,148 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:19 pm | N/A 2035-02-14 | Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director | 173,185 | $0 | 173,185 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:18 pm | N/A 2035-02-14 | Inhibikase Therapeutics Inc. | IKT | Bellini Roberto Director | 190,165 | $0 | 190,165 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:16 pm | N/A 2035-02-14 | Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director | 22,640 | $0 | 22,640 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:11 pm | N/A 2035-02-14 | Inhibikase Therapeutics Inc. | IKT | Munshi Amit Director | 173,185 | $0 | 173,185 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:11 pm | N/A 2035-02-14 | Inhibikase Therapeutics Inc. | IKT | Canner David Director | 139,225 | $0 | 139,225 (Direct) | View |
| 2025-01-21 Option Award(A) | 2025-02-19 8:06 pm | N/A 2026-08-31 | Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director | 68,968 | $0 | 68,968 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:00 pm | N/A 2035-02-14 | Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director | 39,620 | $0 | 39,620 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-22 4:05 pm | N/A 2029-11-28 | Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer | 95,834 | $0 | 95,834 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-22 4:05 pm | N/A 2026-07-28 | Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director | 70,106 | $0 | 70,106 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-22 4:05 pm | N/A 2026-08-31 | Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director | 70,106 | $0 | 70,106 (Indirect) | View |
| 2025-01-21 Option Award | 2025-01-22 4:05 pm | N/A 2025-11-01 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO | 135,716 | $0 | 135,716 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:47 pm | N/A 2035-01-03 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO | 11,582,471 | $0 | 11,582,471 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:43 pm | N/A 2035-01-03 | Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer | 1,139,097 | $0 | 1,139,097 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:39 pm | N/A 2035-01-03 | Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director | 833,290 | $0 | 833,290 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:38 pm | N/A 2035-01-03 | Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director | 833,290 | $0 | 833,290 (Direct) | View |
Ownership | 2024-10-25 5:52 pm | N/A N/A | Inhibikase Therapeutics Inc. | IKT | Sands Capital Life Sciences Pulse Fund II L.P. Sands Capital Ventures LLC SANDS FRANK M. 10% Owner | 0 | $0 | 10,950,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 7:58 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Canner David Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 7:53 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Bellini Roberto Director | 60,000 | $0 | 1,520,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 7:49 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director | 60,000 | $0 | 205,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 7:43 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Munshi Amit Director | 60,000 | $0 | 425,000 (Direct) | View |
| 2024-07-16 Option Award | 2024-07-18 5:27 pm | N/A 2031-07-16 | Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-07-16 Option Award | 2024-07-18 5:23 pm | N/A 2031-07-16 | Inhibikase Therapeutics Inc. | IKT | Dion Gisele Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-07-16 Option Award | 2024-07-18 5:20 pm | N/A 2031-07-16 | Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director | 30,000 | $0 | 30,000 (Indirect) | View |
| 2024-07-16 Option Award | 2024-07-18 5:18 pm | N/A 2031-07-16 | Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 4:47 pm | N/A 2031-04-01 | Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-02 5:14 pm | N/A 2031-04-01 | Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer | 90,000 | $0 | 90,000 (Direct) | View |
Ownership | 2024-04-02 5:12 pm | N/A 2029-11-28 | Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer | 0 | $0 | 5,834 (Direct) | View |